Galecto Inc reports results for the quarter ended in December - Earnings Summary

Damora Therapeutics

12/03/2024 16:13

* Galecto Inc  GLTO.OQ  reported a quarterly adjusted loss
of 24
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -55
cents.  The mean expectation of three analysts for the quarter
was for a loss of 31 cents per share. Wall Street expected
results to range from -35 cents to -25 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galecto Inc's reported EPS for the quarter was a loss
of 24
cents​.
    * The company reported a quarterly loss of $6.48 million.
    * Galecto Inc shares had risen by 9.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 10.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Galecto Inc
is
$6.00 

This summary was machine generated from LSEG data March 12 at
04:12 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.31          -0.24          Beat
 Sep. 30 2023      -0.47          -0.30          Beat
 Jun. 30 2023      -0.59          -0.41          Beat
 Mar. 31 2023      -0.62          -0.51          Beat